00

China Resources Sanjiu Medical & Pharmaceutical Co LtdSHE 000999 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

6.713

Middle

Exchange

XSHE - Shenzhen Stock Exchange

000999.SZ Stock Analysis

00

Neutral

Based on Eyestock quantitative analysis, 000999.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

84/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-9.8 %

Overvalued

Market cap $B

6.713

Dividend yield

4.09 %

Shares outstanding

980.11 B

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the manufacture, development, and sale of pharmaceutical products. The company is headquartered in Shenzhen, Guangdong and currently employs 15,420 full-time employees. The company went IPO on 2000-03-09. The firm's pharmaceutical products include over the counter (OTC) drugs and prescription drugs. The firm's drugs are used for the treatment in cold, gastroenterology, dermatology, pediatrics, cardiovascular and cerebrovascular diseases, anti-tumor, anti-infection, digestive system, orthopedics and other areas. The firm is also involved in packaging and printing and international trading businesses. The firm distributes its products in domestic market and to overseas markets.

View Section: Eyestock Rating